PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Associate Scholar with the Charlotte Lozier Institute.\', \'Executive Director, American Association of Pro-Life Obstetricians and Gynecologists, PO Box 395 Eau Claire, Michigan 49111-0395. Ph 202 230-0997. donna@aaplog.org.\', \'Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI.\', \'Department of Osteopathic Manipulative Medicine, Liberty University College of Osteopathic Medicine.\', \'Associate Professor of Family Medicine, Liberty University College of Osteopathic Medicine.\']
?:citedBy
  • -1
?:creator
?:hasPublicationType
?:journal
  • Issues in law & medicine
is ?:pmid of
?:pmid
?:pmid
  • 33939340
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Deaths and Severe Adverse Events after the use of Mifepristone as an Abortifacient from September 2000 to February 2019.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all